Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asasantin ER Titration Tolerability Study
NCT02269228Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2000
- Primary completion
- Apr 2000
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Phase 1, randomised, double-blind trial of dipyridamole + aspirin in ischemic stroke (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Cumulated headache (intensity x duration) per day based on mean severity per waking hours expressed as area under the curve (AUC) at Day 14. Started Feb 2000; status: completed.
02
Drugs
dipyridamole + aspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02269228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02269228.